Safety assessment of omeprazole use: a review.

Marcela Forgerini Stephania Mieli Patrícia de Carvalho Mastroianni

Published in: Sao Paulo medical journal = Revista paulista de medicina (2019)

Use of omeprazole should be monitored primarily in patients with heart disorders using antiplatelet agents concomitantly, and in newly transplanted patients using mycophenolic acid, in order to avoid serious adverse reactions.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
heart failure
emergency department
adverse drug